Abstract
Annual Review of Physiology
Vol. 67:
147-173
(Volume publication date March 2005)
(doi:10.1146/annurev.physiol.67.040403.130716)
First published online as a Review in Advance on October 25, 2004RNAI AS AN EXPERIMENTAL AND THERAPEUTIC TOOL TO STUDY AND REGULATE PHYSIOLOGICAL AND DISEASE PROCESSES Christopher P. Dillon, Peter Sandy, Alessio Nencioni, Stephan Kissler, Douglas A. Rubinson, and Luk Van ParijsCenter for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; email: cpdillon@mit.edu, psandy@mit.edu, A.nencioni@gmx.net, skissler@mit.edu, drubinso@mit.edu, lukvp@mit.edu ▪ Abstract Over the past four years RNA interference (RNAi) has exploded onto the research scene as a new approach to manipulate gene expression in mammalian systems. More recently, RNAi has garnered much interest as a potential therapeutic strategy. In this review, we briefly summarize the current understanding of RNAi biology and examine how RNAi has been used to study the genetic basis of physiological and disease processes in mammalian systems. We also explore some of the new developments in the use of RNAi for disease therapy and highlight the key challenges that currently limit its application in the laboratory, as well as in the clinical setting. Most recent citing papers (via CrossRef)Dual targeting of the proteasome regulates survival and homing in Waldenstrom macroglobulinemia A. M. Roccaro, X. Leleu, A. Sacco, X. Jia, M. Melhem, A.-S. Moreau, H. T. Ngo, J. Runnels, A. Azab, F. Azab, N. Burwick, M. Farag, S. P. Treon, M. A. Palladino, T. Hideshima, D. Chauhan, K. C. Anderson, I. M. Ghobrial Blood 111(9):4752-4763 (2008) The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia X. Leleu, X. Jia, J. Runnels, H. T. Ngo, A.-S. Moreau, M. Farag, J. A. Spencer, C. M. Pitsillides, E. Hatjiharissi, A. Roccaro, G. O'Sullivan, D. W. McMillin, D. Moreno, T. Kiziltepe, R. Carrasco, S. P. Treon, T. Hideshima, K. C. Anderson, C. P. Lin, I. M. Ghobrial Blood 110(13):4417-4426 (2008) Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenstrom macroglobulinemia A.-S. Moreau, X. Jia, H. T. Ngo, X. Leleu, G. O'Sullivan, Y. Alsayed, A. Leontovich, K. Podar, J. Kutok, J. Daley, S. Lazo-Kallanian, E. Hatjiharissi, M. S. Raab, L. Xu, S. P. Treon, T. Hideshima, K. C. Anderson, I. M. Ghobrial Blood 109(11):4964-4972 (2007) RNA interference technologies and their use in cancer research Current Opinion in Oncology 19(1):50???54 (2007) Leadzyme formed in  vivo interferes with tobacco mosaic virus infection in Nicotiana tabacum FEBS Journal 273(22):5022-5031 (2006)
|
|
|
Users who read this review also read:
| Derek M. Dykxhoorn , Judy Lieberman Annual Review of Medicine. Volume 56, Page 401-423, Feb 2005 Abstract
| Full Text
| PDF (404 KB)
|
Add to Favorites
| Related | |
| Scott E. Martin, Natasha J. Caplen Annual Review of Genomics and Human Genetics. Volume 8, Page 81-108, Sep 2007 Abstract
| Full Text
| PDF (372 KB)
|
Add to Favorites
| Related | |
| Derek M. Dykxhoorn, Judy Lieberman Annual Review of Biomedical Engineering. Volume 8, Page 377-402, Aug 2006 Abstract
| Full Text
| PDF (606 KB)
|
Add to Favorites
| Related | |
| Matthew W. Jones-Rhoades, David P. Bartel, Bonnie Bartel Annual Review of Plant Biology. Volume 57, Page 19-53, Jun 2006 Abstract
| Full Text
| PDF (394 KB)
|
Add to Favorites
| Related | |
|
|